期刊文献+

过氧化物酶增殖物激活受体γ减少血管紧张素Ⅱ诱导的系膜细胞外基质的积聚及其作用机制 被引量:4

Inhibitive effect and mechanism of PPARγ on the ECM production of mesangial cells induced by angiotensin Ⅱ
原文传递
导出
摘要 目的探讨过氧化物酶增殖物激活受体(PPAR)γ1对血管紧张素Ⅱ(Ang Ⅱ)诱导的系膜细胞外基质积聚的抑制作用及其机制。方法脂质体转染质粒pIRES2-EGFP-PPARγ1/ WT(野生型)于系膜细胞,给予AngⅡ(10-7 mol/L)刺激48 h。采用RT-PCR检测TGF-β1、PAI-1、 c-fos、c-jun mRNA表达水平。采用ELISA法检测细胞上清液中TGF-β1和FN浓度。Western印迹观察胞浆中I-κB、NF-κB及胞核中NF-κB、pERK蛋白表达水平。利用PPARγ/与PPRE结合活性测定PPARγ1在系膜细胞中的活性。同时以PPARγ激动剂吡格列酮(6μmol/L)、不具有目的基因PPARγ1的空白质粒pIRES2-EGFP和表达功能缺陷-突变型(DN)PPARγ1的质粒pIRES2- EGFP-mPPARγ1/DN作为对照。结果 PPARγ1过表达能显著性抑制Ang Ⅱ诱导的系膜细胞 TGF-β1、PAI-1的mRNA高表达(P<0.05),同时下调c-fos和c-jun mRNA高表达(P<0.05)。转染PPARγ1/WT能显著降低AngⅡ 48 h刺激下细胞上清液中FN和TGF-β1浓度(P<0.05)。在AngⅡ作用下系膜细胞AT1表达增加(P<0.05),PPARγ1可显著性减少AT1的高表达(P< 0.05)。AngⅡ诱导的系膜细胞pERK表达明显升高,PPARγ1可显著性减少pERK表达(P<0.05)。转染PPARγ1/WT能上调AngⅡ刺激下系膜细胞胞浆中I-κB低表达,同时下调NF-κB由胞浆向细胞核的转移(P<0.05)。转染PPARγ1/DN并无上述作用。吡咯列酮具有与PPARγ1相同的显著性效应。PPARγ1/WT转染组PPARγ1的活性明显高于其他组(P<0.05)。结论 PPAR-γ1过表达能够抑制AngⅡ刺激下系膜细胞外基质的聚积,降低AT1受体蛋白表达,具有直接抗硬化的非代谢性效应,其机制可能是通过抑制ERK/AP-1及NF-κB等信号分子的传递。 Objective To study the inhibitive effect and mechanism of PPARγ1 on the extracellular matrix (ECM) accumulation of mesangial cells induced by Ang Ⅱ .Methods The plasmid of PPARγ1/WT (wild type) was transfected into mesangial cells. After 48 hours of Ang Ⅱ stimulation, the gene expression of TGF-β1, PAI-1, c-los and c-jun was examined by RT-PCR. Protein levels of p-ERK, I-κB and nucleus/cytosol ratio of NF-κB were estimated by Westen-blot. The concentrations of FN and TGF-β1 were estimated by ELISA. The activity of PPARγ1 was examined by specific PPRE binding activity. Plasmid expressing non-functional dominant negative type of mPPARγ1, pIRES2-EGFP-mPPARγ1/DN (DN), and blank plasmid, pIRES2-EGFP (Blank) were used as controls. Effects of 6 μmol/L PPARγ agonist pioglitazone (Pio) were also studied. Results The expression of TGF-β1 and PAI-1 mRNA in mesangial ceils induced by Ang Ⅱ was inhibited by PPARγ1 (P 〈 0.05). The over-expression of PPARγ1 down-regulated the expression of c-fos and c-jun significantly (P 〈 0.05). The expression of AT1 was enhanced by Ang Ⅱ , whereas it was significantly inhibited by the PPARγ1 (P〈0.05). FN and TGF-β1 production were decreased by PPARγ1/WT transfection. PPARγ1 significantly up-regulated the low-expressed I-κB of cytoplasm and down-regulated the transfer of NF-κB from cytoplasm to nuclear by Ang Ⅱ (P 〈0.05). PPARγ1/DN did not show the above effects. Pioglitazone had the same effects as PPARγ1 on these parameters in mesangial cells when treated with AngⅡ medium(P 〈 0.05). The activity of PPAR1γ in the PPARγ1/WT transfected group was significantly higher than that in other groups (P 〈 0.05). Conclusions PPARγ1 inhibits ECM accumulation induced by Ang Ⅱ through suppressing the expression of AT1, which involves its inhibitory effects on activation of ERK/AP-1 and NF-κB pathways.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2006年第5期297-302,共6页 Chinese Journal of Nephrology
基金 国家自然科学基金(30200125)上海市科委基金(03JC14084)
关键词 过氧化物酶增殖物激活受体γ1 噻唑烷二酮类 血管紧张素Ⅱ 转染 系膜细胞 Peroxisome proliferater-aetivated receptor γ1 Thiazolidinediones Angiotensin Ⅱ Transfection Mesangial ceils
作者简介 通信作者:马骥,Email:ma_ji_mail@yahoo.com
  • 相关文献

参考文献14

  • 1Nicholas SB, Kawano Y, Wakino S, et al. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells. Hypertension, 2001, 37(2 Pt 1 ) :722-727.
  • 2Ma L J, Marcantoni C, Linton MF, et al. Peroxisome proliferator - activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int, 2001, 59: 1899-1910.
  • 3Chawla A, Barak Y, Nayg L, et al. PPARγ dependent and independent effects on maerophage gene expression in lipid metabolism and inflammation. Nat Med, 2001, 7:48-52.
  • 4孙晶,马骥,顾勇,林善锬.过氧化物酶体增殖物活化受体γ减少高糖诱导系膜细胞外基质的积聚及其机制[J].中华肾脏病杂志,2004,20(4):255-259. 被引量:8
  • 5孙晶,马骥,郝传明,顾勇,林善锬.表达过氧化物酶增殖物激活受体γ1全长基因质粒的构建及其在转染的系膜细胞中功能的鉴定[J].中华医学杂志,2005,85(33):2338-2343. 被引量:1
  • 6Karim Z, Defontaine N, Paillard M, et al. Protein kinase C isoforms in rat kidney proximal tubule : acute effect of angiotensin Ⅱ. Am J Physiol, 1995, 269(1 Pt 1):C134-C140.
  • 7Largo R, Gomez-Garre D, Soto K, et al. Angiotenzin-converting enzyme is upregulated in the proximal tubuhs of rats with intense proteinuria. Hypertension, 1999, 33 : 732-739.
  • 8Mirza A, Liu SL, Frizell E, et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappa B. Am J Physid, 1997, 272(2 Pt 1) : G281-G288.
  • 9Asakawa M, Takano H, Nagai T, et al. Peroxisome proliferator-activated receptor-γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation, 2002,105 : 1240-1246.
  • 10Sugawara A, Takeuchi K, Uruno A, et al. Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin Ⅱ type 1 receptor genes. Hypertens Res, 2001, 24:229-233.

二级参考文献60

  • 1孙正达,马骥,顾勇,林善锬.吡咯列酮对单肾切除的糖尿病大鼠肾脏纤维化的作用[J].复旦学报(医学版),2003,30(3):235-238. 被引量:4
  • 2Isono M, Cruz MC, Chen S, et al. Extracellular signal-regulated kinase mediates stimulation TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol, 2000, 11: 2222-2230.
  • 3Renard P, Raes M. The proinflammatory transcription factor NFkappa B: a potential target for novel therapeutical strategies.Cell Biol Toxicol, 1999, 15: 341-344.
  • 4Kristina S, Bart S, Johan A. The peroxisome proliferators activiators (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta, 1996, 1302:93-109.
  • 5Isshiki K, Haneda M, Koya D, et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes, 2002, 49:1022-1032.
  • 6Nakamura T, Ushiyama C, Ahimada N, et al. Comparative effects of pioglitazone glibenclamide and voglibose on urinary endothelin-1and albumin excretion in diabetes patients. J Diabetes Complications, 2000, 14: 250-254.
  • 7Ma LJ, Marcantoni C, Linton MF, et al. Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nodiabetic glomerulosclerosis in rats. Kidney Int, 2001, 59:1899-1910.
  • 8Mei CL, Zhang LM, Chen L. The establishment and identification of rat glomelular mesangial cell line. Clin J Nephrol Dial Transplant, 1996, 5: 90-92.
  • 9Spiegelman BM. PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes, 1998, 47: 507-514.
  • 10Jiang C, Ting AT, Seed B. PPARγ agonists inhibits production of monocyte inflammatory cytokines. Nature, 1998, 391: 82-86.

共引文献17

同被引文献40

  • 1刘章锁,程根阳,李海剑,刘书真.罗格列酮对环孢素A所致大鼠成纤维细胞肾毒性的保护作用[J].中华肾脏病杂志,2005,21(5):282-285. 被引量:8
  • 2潘晓勤,王晓燕,姜新猷.肾小球系膜细胞培养及鉴定[J].南京医科大学学报(自然科学版),1995,15(1):222-223. 被引量:85
  • 3Klahr S, Schreiner G, Ichkawa I, et al. The progression of renal disease. N Engl J Med, 1988, 318: 1657-1666.
  • 4Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin Ⅱ signaling. Regul Pept, 2000, 91: 21-27.
  • 5Zhang A, Ding G, Huang S, et al. c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells. Am J Physiol Renal Physiol, 2005, 288:F1118-F1124.
  • 6Zhang A, Dong Z, Yang T. Prostaglandin D2 inhibits TGF- betal-induced epithelial-to-mesenchymal transition in MDCK cells. Am J Physiol Renal Physiol, 2006, 291: F1332- F1342.
  • 7Zhang A, Wang MH, Dong Z, et al. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenehymal transition: interaction with hepatocyte growth factor. Am J Physiol Renal Physiol, 2006, 291: F1323-F1331.
  • 8Tenopoulou M, Doulias PT, Barbouti A, et al. Role of compartmentalized redoxactive iron in hydrogen peroxide- induced DNA damage and apoptosis. Biochem J, 2005, 387: 703-710.
  • 9Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal, 2006, 8: 1597-1607.
  • 10Gorin Y, Block K, Hemandez J, et al. Nox4 NAD (P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem, 2005, 280: 39616-39626.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部